Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zdravka Medarova

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Journal of Lipid Research|July 13, 2011
Unique sphingomyelin patches are targets of a beta-cell-specific antibodyAmol Kavishwar, Zdravka Medarova, Anna Moore
Methods in Molecular Biology (Clifton, N.J.)|November 5, 2015
Controlling RNA Expression in Cancer Using Iron Oxide Nanoparticles Detectable by MRI and In Vivo Optical ImagingZdravka Medarova, Mustafa Balcioglu, Mehmet V Yigit
Pharmaceutical Research|January 26, 2012
Magnetic nanoparticles for cancer diagnosis and therapyMehmet V Yigit, Anna Moore, Zdravka Medarova
Frontiers in Oncology|July 26, 2018
New Directions in the Study and Treatment of Metastatic CancerByunghee Yoo, Bryan C Fuchs, Zdravka Medarova
Frontiers in Oncology|January 10, 2018
Guidelines for Rational Cancer TherapeuticsByunghee Yoo, Ann-Marie Billig, Zdravka Medarova
Scientific Reports|February 3, 2021
MiRNA10b-directed nanotherapy effectively targets brain metastases from breast cancerByunghee Yoo, Alana Ross, Pamela Pantazopoulos, et al.
Cancer Research|January 15, 2009
Multiparametric monitoring of tumor response to chemotherapy by noninvasive imagingZdravka Medarova, Leonid Rashkovetsky, Pamela Pantazopoulos, et al.
Experimental Biology and Medicine (Maywood, N.J.)|February 22, 2002
Alloantigen system L affects the outcome of rous sarcomasZdravka Medarova, W Elwood Briles, Robert L Taylor
Cancer Research|March 5, 2004
In vivo targeting of underglycosylated MUC-1 tumor antigen using a multimodal imaging probeAnna Moore, Zdravka Medarova, Andreas Potthast, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 5, 2009
Development and application of a dual-purpose nanoparticle platform for delivery and imaging of siRNA in tumorsZdravka Medarova, Mohanraja Kumar, Shu-wing Ng, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Journal of Lipid Research|July 13, 2011
Unique sphingomyelin patches are targets of a beta-cell-specific antibodyAmol Kavishwar, Zdravka Medarova, Anna Moore
Methods in Molecular Biology (Clifton, N.J.)|November 5, 2015
Controlling RNA Expression in Cancer Using Iron Oxide Nanoparticles Detectable by MRI and In Vivo Optical ImagingZdravka Medarova, Mustafa Balcioglu, Mehmet V Yigit
Pharmaceutical Research|January 26, 2012
Magnetic nanoparticles for cancer diagnosis and therapyMehmet V Yigit, Anna Moore, Zdravka Medarova
Frontiers in Oncology|July 26, 2018
New Directions in the Study and Treatment of Metastatic CancerByunghee Yoo, Bryan C Fuchs, Zdravka Medarova
Frontiers in Oncology|January 10, 2018
Guidelines for Rational Cancer TherapeuticsByunghee Yoo, Ann-Marie Billig, Zdravka Medarova
Scientific Reports|February 3, 2021
MiRNA10b-directed nanotherapy effectively targets brain metastases from breast cancerByunghee Yoo, Alana Ross, Pamela Pantazopoulos, et al.
Cancer Research|January 15, 2009
Multiparametric monitoring of tumor response to chemotherapy by noninvasive imagingZdravka Medarova, Leonid Rashkovetsky, Pamela Pantazopoulos, et al.
Experimental Biology and Medicine (Maywood, N.J.)|February 22, 2002
Alloantigen system L affects the outcome of rous sarcomasZdravka Medarova, W Elwood Briles, Robert L Taylor
Cancer Research|March 5, 2004
In vivo targeting of underglycosylated MUC-1 tumor antigen using a multimodal imaging probeAnna Moore, Zdravka Medarova, Andreas Potthast, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 5, 2009
Development and application of a dual-purpose nanoparticle platform for delivery and imaging of siRNA in tumorsZdravka Medarova, Mohanraja Kumar, Shu-wing Ng, et al.
Pageof 7